Glutamate Decarboxylase 2, Human, Recombinant

3 trials

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

0 Recruiting

3 Completed trials

2 Sponsors

9 Countries

Phase III

Phase II

Phase III: 1 Phase II: 2

Oversight events:

1 serious breach 8 temporary halts 1 unexpected event across 1 trial

View oversight register →

Indications tested

Type 1 diabetes mellitus 1

Sponsors using this IMP

Diamyd Medical AB 2 Norwegian University Of Science And Technolology 1

All trials

3 total

Testing LADA diabetes status 3 years after treatment with intranodal GAD-alum. Ended

2023-509021-53-00 Phase II 2 countries Norwegian University Of Science And Technolology
A Study to evaluate the safety and feasibility of Diamyd® in individuals at risk for Type 1 diabetes Ended

2024-513350-30-00 Phase II 1 country Diamyd Medical AB
A clinical study to investigate if the investigational drug Diamyd is safe and can preserve insulin production and secretion in adolescents … Ended

2024-513304-33-00 Phase III 8 countries Diamyd Medical AB

Showing 1–3 of 3 trials

← All drugs A–Z